Novel non-cross resistant diaminoanthraquinones as potential chemotherapeutic agents.

Abstract:

:A novel series of diaminoanthraquinones was discovered initially as protein kinase C inhibitors with IC50s in the 50-100 microM range. They exhibited potent tumor cell growth inhibitory activity in vitro without cross resistance to adriamycin. Further evaluation of two of the most active compounds NSC 639365 (3) and NSC 639366 (4) in human tumor cloning assay showed potent cytocidal activity. The results suggest therapeutical potentials against human tumors.

journal_name

J Med Chem

authors

Jiang JB,Johnson MG,Defauw JM,Beine TM,Ballas LM,Janzen WP,Loomis CR,Seldin J,Cofield D,Adams L

doi

10.1021/jm00101a001

keywords:

subject

Has Abstract,Author List Incomplete

pub_date

1992-11-13 00:00:00

pages

4259-63

issue

23

eissn

0022-2623

issn

1520-4804

journal_volume

35

pub_type

杂志文章